Tage Ramakrishna

Tage Ramakrishna, M.D. serves as the Chief Medical Officer and President of Global Research and Development at Bausch Health Companies Inc. Previously, Tage held the position of Vice President of Clinical Research at Progenics Pharmaceuticals and Vice President of International Drug Safety at Nycomed. Additionally, Tage has experience as a Medical Director at both Insmed and The Degge Group, contributing significant expertise in medical leadership and drug development.